本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

BETTERLIFE PHARMA INC.

0.0634
+0.00081.28%
成交量:1,515.00
成交额:96.08
市值:1,002.88万
市盈率:- -
高:0.0634
开:0.0634
低:0.0634
收:0.0626
52周最高:0.1269
52周最低:0.0476
股本:1.58亿
流通股本:1.10亿
量比:0.08
换手率:0.00%
股息:- -
股息率:- -
净资产收益率:-4416.54%
总资产收益率:-357.33%
市净率:-1.47
市盈率(LYR):- -

数据加载中...

2025/06/02

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/05/30

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/06/07

[修订]年度报告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2023/06/01

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/06/06

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/06/05

[修订]年度报告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/06/01

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/06/17

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2019/05/21

重要事件披露

8-K - Current report
2019/05/03

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2019/02/04

重要事件披露

8-K - Current report
2018/12/19

重要事件披露

8-K - Current report
2018/12/18

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2018/11/06

重要事件披露

8-K - Current report
2018/09/18

重要事件披露

8-K - Current report
2018/09/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2018/06/19

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2018/05/16

重要事件披露

8-K/A [Amend] - Current report
2018/05/01

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2018/03/12

重要事件披露

8-K - Current report